Asheville, North Carolina. April 8, 2018
The board of directors of Genova Diagnostics is pleased to announce that it has appointed Jeff Ledford to be the company's next president and chief executive officer, effective March 30, 2019. Mr. Ledford has been with Genova for 20 years and most recently served as Vice President of Laboratory Operations. He has been instrumental in new product development, LEAN Six Sigma implementation, and business development worldwide. He holds an MBA from The Terry School of Business at the University of Georgia.
Previous president and chief executive officer, Chris Smith, has moved on to new opportunities. Mr. Smith had been with Genova since 2006 and had served as president since 2015.
Genova Diagnostics is a privately held company, majority owned by Levine Leichtman Capital Partners, a private investment firm headquartered in Beverly Hills, California.
For questions, Contact Us.